Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune Targeting

Pre-existing antibodies (Abs) to AAV pose a critical challenge for the translation of gene therapies. No effective approach is available to overcome pre-existing Abs. Given the complexity of Ab production, overcoming pre-existing Abs will require broad immune targeting. We generated a mouse model of...

Descripción completa

Detalles Bibliográficos
Autores principales: Velazquez, Victoria M., Meadows, Aaron S., Pineda, Ricardo J., Camboni, Marybeth, McCarty, Douglas M., Fu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363314/
https://www.ncbi.nlm.nih.gov/pubmed/28345001
http://dx.doi.org/10.1016/j.omtm.2017.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363314/
https://www.ncbi.nlm.nih.gov/pubmed/28345001
http://dx.doi.org/10.1016/j.omtm.2017.01.003

Ejemplares similares